One of The Latest Dermal Fillers
EMERVEL® is available in our Markham, Mississauga, Oakville, Milton, and Waterloo clinics. This state of the art dermal filler offers the highest degree of safety, while also offering more moldability, and less swelling for the client.
Our nurse injectors use Cannula needles to administer EMERVEL® in order to minimize bruising and swelling after treatment. Cannula needles are preferred over sharp tipped needles, as often, sharp tipped needles result in more discomfort during treatments and bruising after treatment.
*Results may vary*
Emervel® has been reported to last upwards of 18 months, which is much longer than other dermal fillers, typically lasting 4-6 months. This brand of dermal fillers was designed to focus not on only fine lines, but rather the face as a whole with its varied product line and capability of restoring a refreshing youthfulness to the face. Both men and women will enjoy a more defined and revitalized look that this line offers.
What Is Emervel®?
Emervel® is a dermal filler brand that was developed by Galderma. It is a hyaluronic acid-based dermal filler that was developed to restore volume and smooth out fine lines and wrinkles. It is a non-permanent filler that can enhance the shape of your facial structure and create a more defined look. Emervel® is commonly being used as a substitute for rhinoplasty, as it is a safe line that has undergone extensive research before entering the market. Emervel® dermal fillers are a fantastic alternative to cosmetic surgery, as it is not a permanent substance so there is little risk involved, anesthesia is not required for treatment as it is similar to any other injectable treatment, and there is little to no down time after treatment.
Emervel® can also be used to achieve fuller, more symmetrical-looking lips, enhancing cheek bone definition, and other facial features so that you can achieve or maintain a more youthful-looking appearance.
To learn more about Emervel® book a free consultation with one of our nurse injectors today.